Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract.
BACKGROUND
The ability of a bacterial strain to competitively exclude or displace other strains can be attributed to the production of narrow spectrum antimicrobials, the bacteriocins. In an attempt to evaluate the importance of bacteriocin production for Escherichia coli strain residence in the gastrointestinal tract, a murine model experimental evolution study was undertaken.


RESULTS
Six colicin-producing, yet otherwise isogenic, E. coli strains were administered and established in the large intestine of streptomycin-treated mice. The strains' persistence, population density, and doubling time were monitored over a period of 112 days. Early in the experiment only minor differences in population density between the various colicin-producing and the non-producing control strains were detected. However, over time, the density of the control strains plummeted, while that of the colicin-producing strains remained significantly higher (F(7,66) = 2.317; P < 0.0008).


CONCLUSIONS
The data presented here support prior claims that bacteriocin production may play a significant role in the colonization of E. coli in the gastrointestinal tract. Further, this study suggests that the ability to produce bacteriocins may prove to be a critical factor in determining the success of establishing probiotic E. coli in the gastrointestinal tract of humans and animals.
Gillor
Osnat
O
Zuckerberg Institute for Water Research, J Blaustein Institutes for Desert Research, Ben-Gurion University, Israel. gilloro@bgu.ac.il
Giladi
Itamar
I
Riley
Margaret A
MA
D000818:Animals; D001430:Bacteriocins / Q000096:biosynthesis; D003087:Colicins / Q000096:biosynthesis*; D004926:Escherichia coli / Q000378:metabolism / Q000472:pathogenicity*; D004927:Escherichia coli Infections / Q000382:microbiology*; D005260:Female; D041981:Gastrointestinal Tract / Q000382:microbiology*; D051379:Mice; D010641:Phenotype
D001430:Bacteriocins; D003087:Colicins
Br J Nutr. 2002 May;87 Suppl 2:S241-6
12088524
J Appl Microbiol. 2006 Apr;100(4):821-9
16553738
J Dairy Sci. 1999 May;82(5):863-9
10342225
Microbiol Mol Biol Rev. 2007 Mar;71(1):158-229
17347522
Clin Microbiol Infect. 2005 Dec;11(12):958-66
16307549
J Theor Biol. 1997 Mar 21;185(2):165-71
9344720
Nutr Rev. 2006 Jun;64(6):265-74
16808112
Arch Microbiol. 1994;161(3):199-206
8161282
Am J Clin Nutr. 2001 Jun;73(6):1147S-1151S
11393193
J Nutr. 2000 Feb;130(2S Suppl):384S-390S
10721912
J Clin Microbiol. 1984 Jul;20(1):47-50
6430955
Microbiology (Reading). 2006 Nov;152(Pt 11):3239-3244
17074895
Am J Physiol. 1999 Apr;276(4):G941-50
10198338
Annu Rev Microbiol. 2002;56:117-37
12142491
Inflamm Bowel Dis. 2008 Jul;14(7):1012-8
18240278
FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):223-9
15039098
Nutr J. 2003 Oct 09;2:11
14613507
Appl Microbiol Biotechnol. 2008 Dec;81(4):591-606
18853155
Proc Natl Acad Sci U S A. 1983 Jan;80(2):579-83
6403939
Clin Diagn Lab Immunol. 1999 May;6(3):434-6
10225851
Plasmid. 2008 Jan;59(1):1-10
17936903
J Gen Microbiol. 1992 Jul;138(7):1345-52
1512564
Infect Immun. 2007 Apr;75(4):1565-76
17220307
Digestion. 2006;73 Suppl 1:5-12
16498248
Microbiology (Reading). 2003 Sep;149(Pt 9):2557-2570
12949180
Eur J Pediatr. 2007 Apr;166(4):311-8
17287932
Infect Immun. 2005 Feb;73(2):894-904
15664931
Microbiology (Reading). 2007 Sep;153(Pt 9):2823-2827
17768227
Proc Biol Sci. 2004 Jul 22;271(1547):1529-35
15306326
Appl Environ Microbiol. 2004 Oct;70(10):6053-60
15466550
Microb Pathog. 1994 Nov;17(5):301-11
7723657
Appl Environ Microbiol. 2006 Mar;72(3):2170-7
16517668
Microbiology (Reading). 2007 Oct;153(Pt 10):3563-3571
17906153
Anim Health Res Rev. 2005 Jun;6(1):105-18
16164012
Nature. 2004 Mar 25;428(6981):412-4
15042087
J Appl Microbiol. 2007 Dec;103(6):2392-400
18045424
Appl Environ Microbiol. 1999 Jan;65(1):351-4
9872808
Nature. 2002 Jul 11;418(6894):171-4
12110887